Curt Eyster
R&D / Engineering Advisor

At C2C Consultancy, Curt Eyster brings extensive expertise in medical device R&D and engineering, guiding innovative technologies from concept through successful commercialization. Curt specializes in complex system development, including pulsed electric field ablation, radiofrequency ablation, drug delivery systems, patient monitoring technologies, steerable catheters, and point-of-care diagnostics. He has demonstrated leadership across startup ventures and multinational corporations, skillfully navigating global regulatory pathways, including EU MDR, PMA, 510(k), CFDA, and PMDA approvals. Curt's proven track record includes senior R&D roles at CardioFocus, Galvanize Electrophysiology, Gala Therapeutics, Biosense Webster, Ethicon Endo-Surgery, and LifeScan. Passionate about impacting patient care, Curt excels at building and leading high-performing teams that deliver exceptional product innovations and clinical outcomes.